Sign in
VRCDF Stock Price, Chart, Stats & News
Verici Dx plc
Save
Verici Dx plc (VRCDF) does not currently pay a dividend.
6.86M
Market cap
–
Current P/E
–
Forward P/E
VRCDF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Diagnostics & Research
Industry
Verici Dx plc is an immuno-diagnostics developer primarily dedicated to innovations within the kidney transplantation field. It creates both prognostic (predictive) and diagnostic (identifying current conditions) assays specifically designed for kidney transplant recipients. Its developmental pipeline currently features several key tests: Clarava, a pre-transplant prognostic tool designed to assess the risk of early acute rejection.
Similar securities
Based on sector and market capitalization
Report issue